Valuation dashboard for UnitedHealth Group Incorporated (UNH) with P/E 23.91, P/B 3.42, EV/EBITDA 15.37 and dividend yield 2.44%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services.
Analysis Summary
UnitedHealth Group Incorporated reported revenue of $447.57B in the most recent fiscal year, growing at a 5-year CAGR of 11.7%. Net income reached $12.06B, with a -4.8% 5-year CAGR.
Trailing-twelve-month margins: gross margin 22.5%, operating margin 4.8%, net margin 3.1%.
At the current price of $378.58, UNH trades at a P/E of 23.91 and an ROE of 12.81%. Market capitalisation stands at $343.8B, placing it among large-cap names.
Balance sheet quality for UNH: current ratio of 0.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 23.91 |
| Price / Book | 3.42 |
| EV / EBITDA | 15.37 |
| Dividend Yield | 2.44% |
Valuation Models
| DCF Fair Value | $254.70 |
| vs Current Price | -32.7% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| UNH | UnitedHealth Group Incorporated | $337.7B | 23.91 | 3.42 | 12.8% |
| MRK | Merck & Co., Inc. | $356.4B | 115.44 | 8.51 | 6.6% |
| AZN | AstraZeneca PLC | $252.8B | 23.36 | 4.81 | 21.7% |
| ABT | Abbott Laboratories | $168.7B | 31.35 | 3.33 | 12.5% |
| NVO | Novo Nordisk A/S | $170.1B | 9.36 | 4.91 | 59.1% |
| CVS | CVS Health Corp. | $110.3B | 22.87 | 1.38 | 6.4% |
| CI | Cigna Corporation | $71.5B | 11.16 | 1.68 | 14.3% |
| ELV | Elevance Health Inc. | $83.8B | 17.17 | 1.88 | 12.9% |
Price
| Price | $378.58 |
| Market Cap | $343.8B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 12.81% |
| Return on Invested Capital | 8.23% |
| Return on Assets | 3.89% |
| Gross Margin | 22.49% |
| Operating Margin | 4.82% |
| Net Margin | 3.14% |
Related companies: ABT · AZN · CI · CVS · ELV · HUM · MRK
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of UNH: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks